BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ellis RJ, Wang Y, Stevenson HS, Boufraqech M, Patel D, Nilubol N, Davis S, Edelman DC, Merino MJ, He M, Zhang L, Meltzer PS, Kebebew E. Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. J Clin Endocrinol Metab 2014;99:E329-37. [PMID: 24423287 DOI: 10.1210/jc.2013-2749] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Chen Z, Liu X, Liu F, Zhang G, Tu H, Lin W, Lin H. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm. Aging (Albany NY) 2021;13:20164-78. [PMID: 34456184 DOI: 10.18632/aging.203338] [Reference Citation Analysis]
2 Grassi ES, Ghiandai V, Persani L. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies. J Clin Med 2021;10:1455. [PMID: 33916320 DOI: 10.3390/jcm10071455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Han R, Sun W, Huang J, Shao L, Zhang H. Sex-biased DNA methylation in papillary thyroid cancer. Biomark Med 2021;15:109-20. [PMID: 33464123 DOI: 10.2217/bmm-2020-0215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pitto L, Gorini F, Bianchi F, Guzzolino E. New Insights into Mechanisms of Endocrine-Disrupting Chemicals in Thyroid Diseases: The Epigenetic Way. Int J Environ Res Public Health 2020;17:E7787. [PMID: 33114343 DOI: 10.3390/ijerph17217787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Li S, Tollefsbol TO. DNA methylation methods: Global DNA methylation and methylomic analyses. Methods 2021;187:28-43. [PMID: 33039572 DOI: 10.1016/j.ymeth.2020.10.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
6 Veschi V, Verona F, Lo Iacono M, D'Accardo C, Porcelli G, Turdo A, Gaggianesi M, Forte S, Giuffrida D, Memeo L, Todaro M. Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. Front Endocrinol (Lausanne) 2020;11:566. [PMID: 32982967 DOI: 10.3389/fendo.2020.00566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
7 Tan J, Liu L, Zuo Z, Song B, Cai T, Ding D, Lu Y, Ye X. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Oncol Rep 2020;44:1489-501. [PMID: 32945494 DOI: 10.3892/or.2020.7712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Vos LD, Dietrich J, Strieth S, Bootz F, Dietrich D, Franzen A. PD-1 , CTLA4 , PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma. Immunotherapy 2020;12:903-20. [DOI: 10.2217/imt-2020-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zafon C, Gil J, Pérez-González B, Jordà M. DNA methylation in thyroid cancer. Endocr Relat Cancer 2019;26:R415-39. [PMID: 31035251 DOI: 10.1530/ERC-19-0093] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 15.0] [Reference Citation Analysis]
10 Wang M, Zhang K, Ngo V, Liu C, Fan S, Whitaker JW, Chen Y, Ai R, Chen Z, Wang J, Zheng L, Wang W. Identification of DNA motifs that regulate DNA methylation. Nucleic Acids Res 2019;47:6753-68. [PMID: 31334813 DOI: 10.1093/nar/gkz483] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
11 Boufraqech M, Nilubol N. Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome. Cancers (Basel) 2019;11:E1988. [PMID: 31835496 DOI: 10.3390/cancers11121988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Botezatu A, Iancu IV, Plesa A, Manda D, Popa O, Bostan M, Mihaila M, Albulescu A, Fudulu A, Vladoiu SV, Huica I, Dobrescu R, Anton G, Badiu C. Methylation of tumour suppressor genes associated with thyroid cancer. Cancer Biomark 2019;25:53-65. [PMID: 31006665 DOI: 10.3233/CBM-182265] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
13 Gómez-Pérez AM, Cornejo Pareja IM, García Alemán J, Coín Aragüez L, Sebastián Ochoa A, Alcaide Torres J, Molina Vega M, Clu Fernández C, Mancha Doblas I, Tinahones FJ. New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR-146, miR-221 and miR-222 levels in the evolution of the disease. Clin Endocrinol (Oxf) 2019;91:187-94. [PMID: 30887564 DOI: 10.1111/cen.13972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
14 Shakiba E, Movahedi M, Majd A, Hedayati M. Investigating the expression and promoter methylation of RET gene in patients with medullary thyroid cancer with unmutated RET. J Cell Physiol 2019;234:16304-11. [DOI: 10.1002/jcp.28295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang M, Zhang K, Ngo V, Liu C, Fan S, Whitaker JW, Chen Y, Ai R, Chen Z, Wang J, Zheng L, Wang W. Identification of DNA motifs that regulate DNA methylation.. [DOI: 10.1101/573352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Affinito O, Salerno P, D'Alessio A, Cuomo M, Florio E, Carlomagno F, Proietti A, Giannini R, Basolo F, Chiariotti L, Cocozza S, Santoro M. Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms. Endocr Relat Cancer 2019;26:451-62. [PMID: 30753136 DOI: 10.1530/ERC-18-0308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Buj R, Mallona I, Díez-Villanueva A, Zafon C, Mate JL, Roca M, Puig-Domingo M, Reverter JL, Mauricio D, Peinado MA, Jordà M. Kallikreins Stepwise Scoring Reveals Three Subtypes of Papillary Thyroid Cancer with Prognostic Implications. Thyroid 2018;28:601-12. [PMID: 29635968 DOI: 10.1089/thy.2017.0501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
18 Zhao Y, Zhong L, Yi H. A review on the mechanism of iodide metabolic dysfunction in differentiated thyroid cancer. Molecular and Cellular Endocrinology 2019;479:71-7. [DOI: 10.1016/j.mce.2018.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
19 Valvo V, Nucera C. Coding Molecular Determinants of Thyroid Cancer Development and Progression. Endocrinol Metab Clin North Am 2019;48:37-59. [PMID: 30717910 DOI: 10.1016/j.ecl.2018.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
20 Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes. Mol Diagn Ther 2018;22:41-56. [PMID: 28986854 DOI: 10.1007/s40291-017-0303-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
21 Yim JH, Choi AH, Li AX, Qin H, Chang S, Tong ST, Chu P, Kim BW, Schmolze D, Lew R, Ibrahim Y, Poroyko VA, Salvatierra S, Baker A, Wang J, Wu X, Pfeifer GP, Fong Y, Hahn MA. Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics. Clin Cancer Res 2019;25:544-51. [PMID: 30093451 DOI: 10.1158/1078-0432.CCR-18-0841] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
22 Klein Hesselink EN, Zafon C, Villalmanzo N, Iglesias C, van Hemel BM, Klein Hesselink MS, Montero-Conde C, Buj R, Mauricio D, Peinado MA, Puig-Domingo M, Riesco-Eizaguirre G, Reverter JL, Robledo M, Links TP, Jordà M. Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer. J Clin Endocrinol Metab 2018;103:397-406. [PMID: 29165662 DOI: 10.1210/jc.2017-01613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
23 Tan J, Qian X, Song B, An X, Cai T, Zuo Z, Ding D, Lu Y, Li H. Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer. Oncol Rep 2018;40:111-22. [PMID: 29749483 DOI: 10.3892/or.2018.6428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
24 Penha RCC, Buexm LA, Rodrigues FR, de Castro TP, Santos MCS, Fortunato RS, Carvalho DP, Cardoso-Weide LC, Ferreira ACF. NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells. BMC Cancer 2018;18:498. [PMID: 29716526 DOI: 10.1186/s12885-018-4399-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Bisarro Dos Reis M, Barros-Filho MC, Marchi FA, Beltrami CM, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017;102:4089-4099. [PMID: 28938489 DOI: 10.1210/jc.2017-00881] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
26 Niu H, Yang J, Yang K, Huang Y. The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA). Medicine (Baltimore) 2017;96:e8630. [PMID: 29145283 DOI: 10.1097/MD.0000000000008630] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
27 Jin Y, Jin W, Zheng Z, Chen E, Wang Q, Wang Y, Wang O, Zhang X. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer. Biochem Biophys Res Commun 2017;492:323-30. [PMID: 28859983 DOI: 10.1016/j.bbrc.2017.08.114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
28 Kotian S, Zhang L, Boufraqech M, Gaskins K, Gara SK, Quezado M, Nilubol N, Kebebew E. Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases. Clin Cancer Res 2017;23:5044-54. [PMID: 28600475 DOI: 10.1158/1078-0432.CCR-17-1043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
29 Beltrami CM, Dos Reis MB, Barros-Filho MC, Marchi FA, Kuasne H, Pinto CAL, Ambatipudi S, Herceg Z, Kowalski LP, Rogatto SR. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas. Clin Epigenetics 2017;9:45. [PMID: 28469731 DOI: 10.1186/s13148-017-0346-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
30 Neary JL, Perez SM, Peterson K, Lodge DJ, Carless MA. Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia. Genomics 2017;109:204-13. [PMID: 28365388 DOI: 10.1016/j.ygeno.2017.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
31 Zhang S, Wang Y, Chen M, Sun L, Han J, Elena VK, Qiao H. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma. Sci Rep 2017;7:44033. [PMID: 28272462 DOI: 10.1038/srep44033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
32 Sorrenti S, Baldini E, Tartaglia F, Catania A, Arcieri S, Pironi D, Calò PG, Filippini A, Ulisse S. Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy. Aging Clin Exp Res 2017;29:7-13. [PMID: 27832468 DOI: 10.1007/s40520-016-0654-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Rodríguez-Rodero S, Delgado-Álvarez E, Díaz-Naya L, Martín Nieto A, Menéndez Torre E. Epigenetic modulators of thyroid cancer. Endocrinol Diabetes Nutr 2017;64:44-56. [PMID: 28440770 DOI: 10.1016/j.endinu.2016.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Shou F, Xu F, Li G, Zhao Z, Mao Y, Yang F, Wang H, Guo H. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis. Onco Targets Ther 2017;10:247-57. [PMID: 28123306 DOI: 10.2147/OTT.S124417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
35 Rodríguez-rodero S, Delgado-álvarez E, Díaz-naya L, Martín Nieto A, Menéndez Torre E. Epigenetic modulators of thyroid cancer. Endocrinología, Diabetes y Nutrición (English ed ) 2017;64:44-56. [DOI: 10.1016/j.endien.2017.02.006] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 White MG, Nagar S, Aschebrook-Kilfoy B, Jasmine F, Kibriya MG, Ahsan H, Angelos P, Kaplan EL, Grogan RH. Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis. Ann Surg Oncol 2016;23:2302-9. [PMID: 26979305 DOI: 10.1245/s10434-016-5185-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
37 Antonello Z, Nucera C. Epigenetic Control in Human Normal Follicular Thyroid Cells and in Thyroid Carcinoma. Medical Epigenetics 2016. [DOI: 10.1016/b978-0-12-803239-8.00026-0] [Reference Citation Analysis]
38 Sun W, Chatterjee B, Wang Y, Stevenson HS, Edelman DC, Meltzer PS, Barr FG. Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. Mod Pathol 2015;28:1214-24. [PMID: 26226845 DOI: 10.1038/modpathol.2015.82] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
39 Ma WY, Hsiung LC, Wang CH, Chiang CL, Lin CH, Huang CS, Wo AM. A novel 96well-formatted micro-gap plate enabling drug response profiling on primary tumour samples. Sci Rep 2015;5:9656. [PMID: 25866290 DOI: 10.1038/srep09656] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
40 Cao S, Yan B, Lu Y, Zhang G, Li J, Zhai W, Guo W, Zhang S. Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue. Clinics and Research in Hepatology and Gastroenterology 2015;39:198-204. [DOI: 10.1016/j.clinre.2014.09.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
41 Cancer Genome Atlas Research Network. . Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676-690. [PMID: 25417114 DOI: 10.1016/j.cell.2014.09.050] [Cited by in Crossref: 1650] [Cited by in F6Publishing: 1799] [Article Influence: 235.7] [Reference Citation Analysis]
42 Keelawat S, Thorner PS, Shuangshoti S, Bychkov A, Kitkumthorn N, Rattanatanyong P, Boonyayothin W, Poumsuk U, Ruangvejvorachai P, Mutirangura A. Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis. J Endocrinol Invest 2015;38:725-32. [PMID: 25740063 DOI: 10.1007/s40618-015-0246-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
43 Prescott JD, Zeiger MA. The RET oncogene in papillary thyroid carcinoma: RET Mutations in Papillary Thyroid Ca. Cancer 2015;121:2137-46. [DOI: 10.1002/cncr.29044] [Cited by in Crossref: 48] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
44 Mohammadi-asl J. Epigenetics of Thyroid Cancer. Epigenetics Territory and Cancer 2015. [DOI: 10.1007/978-94-017-9639-2_15] [Reference Citation Analysis]